Investigate.
Establish what happened. Determine why.
An adverse clinical outcome cannot always be understood by examining individual decisions, isolated records or compliance with a single protocol.
Clinical events develop within interconnected systems of people, information, technology, processes and organisational decisions.
The Clinical Investigation Division conducts independent, forensically structured investigations that reconstruct clinical events, assess the integrity of clinical decisions and responses, and examine the systems in which care was delivered.
We establish not only what happened, but how and why it became possible.
The investigative difference
Beyond what the clinical record says.
Clinical documentation is essential evidence. It is not necessarily a complete account of clinical reality.
Records may contain omissions, inconsistencies, retrospective interpretations or accounts that do not fully correspond with contemporaneous observations and actions.
CID examines the relationship between recorded information, available clinical evidence and the actual sequence of care.
Our investigations do not assume that an adverse outcome demonstrates wrongdoing, nor that documentation or procedural compliance establishes that appropriate care occurred.
The evidence determines the findings.
What was documented
- Entries in the clinical record
- Retrospective notes and later accounts
- What was known after the event
What can be independently established
- Contemporaneous observations and actions
- The actual sequence of care
- What was known, or knowable, at the time
We distinguish what was documented from what can be independently established, and what was known at the time from what subsequently became apparent.
CASE — Our investigative framework
CASE.
Six dimensions.
One integrated assessment.
CASE — Clinical Assessment & Systems-Level Evaluation — is CID's structured methodology for investigating clinical events and adverse outcomes.
It examines six interconnected dimensions of clinical performance and system integrity.
01Detection
Whether emerging clinical abnormalities, changes in patient condition and relevant warning signals were recognised.
02Interpretation
Whether available observations and evidence were appropriately understood and incorporated into clinical assessment.
03Response Latency
Whether clinical responses occurred within appropriate timeframes and what delays reveal about clinical and organisational performance.
04Decision Integrity
Whether decisions were reasonable in light of the evidence available, or reasonably knowable, at the time.
05Escalation Integrity
Whether concerns and developing risks were communicated, escalated, acknowledged and acted upon appropriately.
06Governance & Disclosure
Whether clinical records, subsequent explanations and institutional accounts are consistent with the underlying evidence, including relevant disclosure and consent obligations.
These dimensions are examined together, allowing findings to be integrated across clinical decisions, behaviours, processes and systems.
Risk propagation analysis
How risk travels through the clinical system.
Clinical risk does not necessarily remain where it originates.
An unrecognised complication in theatre may become an incomplete handover to intensive care. An omitted observation may affect subsequent interpretation. An unresolved abnormality may be carried forward through ward transfer, discharge and follow-up.
At each transition, clinical information may be preserved, altered, delayed, minimised or lost.
Information and risk across transitions of care
Illustrative example — not drawn from a real case.
CID examines this progression to establish:
- 01Where risk originated or first became detectable
- 02How information and clinical responsibility moved between care settings
- 03Whether information was accurately transferred and interpreted
- 04Where responses or escalation were delayed or ineffective
- 05Whether successive decisions compounded the original risk
- 06Which controls should have interrupted the progression
The objective is to identify not simply the point of failure, but the sequence through which harm developed or opportunities for intervention were lost.
Systems-level governance analysis
When a system works as documented — but not as intended.
Clinical governance extends beyond having policies, procedures and standards in place.
The important question is whether these arrangements actually support safe clinical decisions, timely responses and effective accountability in practice.
CID examines clinical performance against relevant professional standards, clinical guidelines, organisational protocols, procedures and governance obligations.
We assess the relationship between:
Each layer should align with the one above it. The drift between them is where weaknesses appear.
Standards and obligations
What applicable clinical and professional requirements establish.
Policies and protocols
How institutions translate those requirements into operating rules and clinical pathways.
Actual practice
What clinicians, departments and systems demonstrably did during the episode under investigation.
Governance and control
Whether monitoring, oversight, escalation and corrective mechanisms functioned effectively.
Dashed outline: where each layer should sit if fully aligned.
Differences between these layers may reveal weaknesses that conventional compliance assessments do not detect.
From evidence to findings
Structured. Traceable. Independently determined.
CID investigations bring together clinical chronology, contemporaneous evidence, investigative questions, decision analysis, risk propagation and systems-level findings.
Depending on scope, the resulting report may include:
- 01Executive Summary and principal findings
- 02Clinical event chronology and evidence reconstruction
- 03CASE dimensional assessment
- 04Risk propagation and response analysis
- 05Standards, protocols and governance assessment
- 06Integrated findings and supporting evidence
- 07Areas of uncertainty or unresolved evidence
- 08Recommendations for corrective action, further review or referral
Findings distinguish established facts from analytical interpretation and matters requiring further investigation.
The commissioning party does not determine the findings.Commission an investigation
When the clinical account does not adequately explain the outcome.
CID undertakes defined-scope investigations of adverse clinical events, clinical decision-making, institutional responses and systemic safety concerns.
Engagements are subject to an initial assessment of scope, available evidence, independence and investigative suitability.